Remarkable Advances in Liver Self-Transplantation Trials
Clinical trials in liver stem cell transplantation therapy represent a frontier in medical research, particularly for conditions like late-stage...
Takeda’s EoE Drug Eohilia Gets First FDA Approval in US
Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension) for the...
Takeda’s TAK-861 Narcolepsy Phase 3 Trials Set for FY2024
Takeda has announced promising topline results from a Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 (OX2R)...
Survey: Pharma Fears CRO Instability Amid Sector Mergers
Worldwide Clinical Trials has released a survey report on the perceptions of large and midsize contract research organizations (CROs)...
How CROs Are Innovating Clinical Trial Site Payments
The recent IQVIA Clinical Trial Site Payments Webcast shed light on the intricacies of financial management in clinical trials,...
BMS’s Opdivo for Lung Cancer: US & EU Filings Accepted
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics Application (sBLA)...
AstraZeneca Grows US Cell Therapy Production Capacity
AstraZeneca has announced a $300 million investment in a new state-of-the-art facility in Rockville, Maryland, aimed at advancing its...
Roche on RBQM and AI in Clinical Trials: Secrets to Success
In this interview, Michael Torok, Head of Quality Assurance Programs at Roche, delves into the operationalization of RBQM (Risk...
Participant Payments Pulse Check: How and Why to Prioritize Your Strategy
In this exclusive interview, we sit down with Donna Libretti Cooke, JD, a distinguished clinical operations specialized consultant known...
Advancing ClinOps Excellence: The 15th Annual SCOPE Summit 2024
Join us at the 15th Annual SCOPE Summit, scheduled for February 11-14, 2024, in Orlando, Florida, at the Rosen...